Entero Healthcare Solutions Ltd Share Price Today - Entero Healthcare Solutions Ltd Stock Price Live NSE/BSE

Entero Healthcare Solutions Ltd

NSE: ENTERO BSE: 544122

₹1032

(-2.77%)

Wed, 04 Mar 2026, 07:23 am

MTF 5xInvest in Entero Healthcare Solutions Ltd with 5x Leverage Buy with MTF

Market Cap45.08B

PE Ratio39.89

Dividend0

Distribution Services

Medical Distributors

24.5K

Entero Healthcare Solutions Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
4459.44
Net Profit
107.43
P/B
2.88
Sector P/E
57.77
P/E
52.16
EV/EBITDA
24.02
Debt/Equity (Industry)
0.65
Interest Cover (Industry)
4.79
ROCE (Industry)
18.39
RONW (Industry)
17.80
ROE
6.33
ROCE
8.70
Debt/Equity
0.22
EPS (TTM)
26.93
Dividend Yield
0
Book Value
405.95
Interest Cover
4.33

Analysis

No Result Found

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	52.42	52.42	52.42	52.42	52.44
FII	5.14	14.67	17.20	19.92	22.21
DII	16.42	9.65	10.18	9.64	8.77
Public	26.03	23.26	20.19	18.02	16.59
Government	0	0	0	0	0

Technical Analysis

RSI

33.08

MACD

-26.94

50 DMA

1107.39

200 DMA

1150.34

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	1501.33	1293.33	1162.67	1085.33	954.67	877.33	669.33
Fibonacci	1293.33	1213.88	1164.79	1085.33	1005.88	956.79	877.33
Camarilla	1089.20	1070.13	1051.07	1085.33	1012.93	993.87	974.80

Pivots Level: Classic

+416

1501.33

+208

1293.33

+77.33

1162.67

1085.33

Pivot Point

LTP: 1010.40

-130.67

954.67

-208

877.33

-416

669.33

Moving Average

SMAEMA

Period

Value

10-EMA
1053.65
20-EMA
1079.75
30-EMA
1090.62
50-EMA
1096.71
100-EMA
1108.55
200-EMA
1141.00

Announcement Date	Purpose	Action
12 Feb 2026	board-meetings	Quarterly Results
12 Nov 2025	board-meetings	Quarterly Results
18 Jun 2025	agm
05 Aug 2024	agm

Entero Healthcare Solutions Ltd

Aster DM Healthcare Ltd

Narayana Hrudayalaya Ltd

Max Healthcare Institute Ltd

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd

Entero Healthcare Solutions Ltd About

Entero Healthcare Solutions is in the business of distribution and marketing of pharmaceutical products, surgical products and other allied services.

Industry

Trading

Founded

2018

Headquarters

CEO

Sujesh Vasudevan

Employees

Contact

Website

http://www.enterohealthcare.com

jayant.prakash@enterohealthcare.com

Phone

0129-4877300

Location

Plot # I-35 Bldg-B Ind. Area, Phase-I 13/7 Mathura Road, Faridabad, Haryana, 121003

Year	History
2020	The Company achieved positive EBITDA in its second year of being operational. The Company entered into a promotion, marketing and distribution partnership with Roche Products (India) Private Limited.
2021	The Company was recognized as one of The Economic Times - Best Healthcare Brands 2021.
2022	The Company acquired SS Pharma Traders Private Limited, its 32nd acquisition.
2023	The Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of Shareholders. The name of the Company was changed to Entero Healthcare Solutions Limited. A fresh certificate of incorporation was issued by the Registrar of Companies.
2024	The Company acquired Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. The Company Board of Directors approved the acquisition of Devi Pharma Wellness Private Limited. The Company acquired 80% paid-up equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Client Name	Order Side	QTY	Avg Price	Date
SMALLCAP WORLD FUND INC	Sell	2269517	950	29 Dec 2025
ICICI PRUDENTIAL MUTUAL FUND	Buy	2182039	950	29 Dec 2025
AL MEHWAR COMMERCIAL INVESTMENTS L.L.C.	Buy	249847	1399.8	04 Nov 2024
CLSA GLOBAL MARKETS PTE LTD - ODI	Sell	249847	1399.8	04 Nov 2024
STICHTING DEPOSITARY APG EMERGING MARKETS EQUITY POOL	Buy	927203	1305	27 Sept 2024
PRASID UNO FAMILY TRUST	Sell	2400000	1305	27 Sept 2024
MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED	Sell	222732	1188.51	16 Feb 2024
MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED	Buy	222732	1180.3	16 Feb 2024

Entero Healthcare Solutions Ltd News

Entero Healthcare Q3FY26 Revenue Rises to ₹1,067.36 Million

Entero Healthcare Solutions reported Q3FY26 standalone revenue of ₹1,067.36 million, up from ₹1,011.52 million in Q3FY25. However, net profit declined to ₹8.05 million from ₹107.83 million due to exceptional items worth ₹44.97 million related to new labour codes.

12 Feb 2026

co actions results

Entero Healthcare Completes 51.51% Stake Acquisition

Entero Healthcare Solutions Limited has successfully completed the acquisition of a majority 51.51% equity stake in Anand Chemiceutics Private Limited, as announced in regulatory filing.

07 Feb 2026

co actions results

Entero Healthcare Q3FY26 Earnings Call on Feb 7

Entero Healthcare Solutions announces earnings call on February 07, 2026 to discuss Q3FY26 financial results with analysts and investors, hosted by DAM Capital Advisors.

06 Feb 2026

co actions results

Entero Healthcare unit faces 3-day license suspension

Entero Healthcare's subsidiary Atreja Healthcare Solutions gets temporary drug license suspension from Jan 30-Feb 1, 2026, with potential revenue loss of ₹1.88 million for regulatory violations.

27 Jan 2026

stocks

Entero Healthcare Auditor Firm Converts to LLP

Entero Healthcare Solutions' statutory auditor M S K A & Associates has converted to M S K A & Associates LLP effective January 13, 2026, with no change in audit engagement or obligations.

15 Jan 2026

stocks

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800